Intrinsiqq
⚠ Showing the latest available close (Oct 21, 2026, 2 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.
CBRE Group Inc. logoCBRE Group Inc.CBRE
$134.65+0.31%
CBRE Group Inc. logo

CBRE Group Inc.

CBRE

$134.65

+$0.42 (+0.31%)

⊜ Compare
ProfitabilityN/AGrowthSteady growthCash FlowN/AValuationNot cheap
What stands out

Net margin is thin at 2.85%. This may reflect rising credit costs, rate compression, or operational inefficiency.

What's changing

Revenue grew 13.4% YoY.

What deserves caution

At 31x earnings, the multiple is above the banking sector average. Financials rarely sustain elevated multiples through credit cycles.

Valuation context

31.0x earnings. Above the financial-sector median (~13x). The market is pricing in above-average returns or growth, any credit deterioration would compress the multiple quickly.

Price History

-16.3%

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$38.99B
EPS$4.35
P/E30.95
Div. Yield—
Net Margin3.0%
P/Book4.6x
52-Week Range
$124.64$171.61

Profitability & Returns

Revenue (TTM)

$43.71B

▲ +13.4% YoY

Net Income (TTM)

$1.30B

▲ +19.5% YoY

Net Margin

2.98%

P/E

31.0x

Balance Sheet

Total Assets

$30.47B

Equity

$8.40B

Total Debt

$10.81B

Cash & Equiv.

$1.49B

5Y CAGR: +11.2%

Continue Research

SourceComputed from the 10-Q filed 27 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 30 Jul 2026. How this is calculated.

Price from market data, last close as of 21 Oct 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.

Is CBRE Group (CBRE) overvalued?

At a P/E of 31.0 and a price-to-free-cash-flow of 41.6, CBRE Group (CBRE) trades above a two-stage DCF intrinsic value of about $23.61 per share, so at $134.65 the stock looks overvalued (82.5% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.

On quality, CBRE Group scores 46/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.

Frequently asked

What is CBRE Group's fair value?+

Intrinsiqq's two-stage DCF estimates an intrinsic value of about $23.61 per share for CBRE, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $17.71. At today's $134.65, that puts the stock about 82.5% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.

Is CBRE Group a high-quality business?+

CBRE Group scores 46 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 4.5% operating margin and a 8.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.

Is CBRE Group a good stock to buy right now?+

That depends on valuation and quality together, not either alone. CBRE currently trades above its estimated intrinsic value and scores 46/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.

Related stocks: Real Estate

Spot a number that looks wrong? Check it in CBRE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CBRE

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.